BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12015308)

  • 1. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.
    Guerrero-Esteo M; Sanchez-Elsner T; Letamendia A; Bernabeu C
    J Biol Chem; 2002 Aug; 277(32):29197-209. PubMed ID: 12015308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily.
    Radaev S; Zou Z; Huang T; Lafer EM; Hinck AP; Sun PD
    J Biol Chem; 2010 May; 285(19):14806-14. PubMed ID: 20207738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide ligands that use a novel binding site to target both TGF-β receptors.
    Li L; Orner BP; Huang T; Hinck AP; Kiessling LL
    Mol Biosyst; 2010 Dec; 6(12):2392-402. PubMed ID: 20890540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor.
    Rotzer D; Roth M; Lutz M; Lindemann D; Sebald W; Knaus P
    EMBO J; 2001 Feb; 20(3):480-90. PubMed ID: 11157754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TbetaRI/Alk5-independent TbetaRII signaling to ERK1/2 in human skin cells according to distinct levels of TbetaRII expression.
    Bandyopadhyay B; Han A; Dai J; Fan J; Li Y; Chen M; Woodley DT; Li W
    J Cell Sci; 2011 Jan; 124(Pt 1):19-24. PubMed ID: 21172820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational modeling of TGF-β2:TβRI:TβRII receptor complex assembly as mediated by the TGF-β coreceptor betaglycan.
    Madamanchi A; Ingle M; Hinck AP; Umulis DM
    Biophys J; 2023 Apr; 122(7):1342-1354. PubMed ID: 36869592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An engineered transforming growth factor β (TGF-β) monomer that functions as a dominant negative to block TGF-β signaling.
    Kim SK; Barron L; Hinck CS; Petrunak EM; Cano KE; Thangirala A; Iskra B; Brothers M; Vonberg M; Leal B; Richter B; Kodali R; Taylor AB; Du S; Barnes CO; Sulea T; Calero G; Hart PJ; Hart MJ; Demeler B; Hinck AP
    J Biol Chem; 2017 Apr; 292(17):7173-7188. PubMed ID: 28228478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of transforming growth factor-β signals suppresses tumor formation by regulation of tumor microenvironment networks.
    Tokizaki S; Podyma-Inoue KA; Matsumoto T; Takahashi K; Kobayashi M; Ibi H; Uchida S; Iwabuchi S; Harada H; Hashimoto S; Miyazono K; Shirouzu M; Watabe T
    Cancer Sci; 2024 Jan; 115(1):211-226. PubMed ID: 37972575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct endocytic responses of heteromeric and homomeric transforming growth factor beta receptors.
    Anders RA; Arline SL; Doré JJ; Leof EB
    Mol Biol Cell; 1997 Nov; 8(11):2133-43. PubMed ID: 9362058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCN2 Increases TGF-β Receptor Type II Expression in Vascular Smooth Muscle Cells: Essential Role of CCN2 in the TGF-β Pathway Regulation.
    Tejera-Muñoz A; Marquez-Exposito L; Tejedor-Santamaría L; Rayego-Mateos S; Orejudo M; Suarez-Álvarez B; López-Larrea C; Ruíz-Ortega M; Rodrigues-Díez RR
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the TGF-beta1 system in human testicular pathologies.
    Gonzalez CR; Matzkin ME; Frungieri MB; Terradas C; Ponzio R; Puigdomenech E; Levalle O; Calandra RS; Gonzalez-Calvar SI
    Reprod Biol Endocrinol; 2010 Dec; 8():148. PubMed ID: 21126344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling long-term signaling: receptor dynamics determine attenuation and refractory behavior of the TGF-β pathway.
    Vizán P; Miller DS; Gori I; Das D; Schmierer B; Hill CS
    Sci Signal; 2013 Dec; 6(305):ra106. PubMed ID: 24327760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TβRI/II kinase inhibition with LY2109761.
    Connolly EC; Saunier EF; Quigley D; Luu MT; De Sapio A; Hann B; Yingling JM; Akhurst RJ
    Cancer Res; 2011 Mar; 71(6):2339-49. PubMed ID: 21282335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical and functional interactions between type I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A.
    Griswold-Prenner I; Kamibayashi C; Maruoka EM; Mumby MC; Derynck R
    Mol Cell Biol; 1998 Nov; 18(11):6595-604. PubMed ID: 9774674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IQGAP1 suppresses TβRII-mediated myofibroblastic activation and metastatic growth in liver.
    Liu C; Billadeau DD; Abdelhakim H; Leof E; Kaibuchi K; Bernabeu C; Bloom GS; Yang L; Boardman L; Shah VH; Kang N
    J Clin Invest; 2013 Mar; 123(3):1138-56. PubMed ID: 23454766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGM6, a helminth secretory product, mimics TGF-β binding to TβRII to antagonize TGF-β signaling in fibroblasts.
    White SE; Schwartze TA; Mukundan A; Schoenherr C; Singh SP; van Dinther M; Cunningham KT; White MPJ; Campion T; Pritchard J; Hinck CS; Ten Dijke P; Inman G; Maizels RM; Hinck AP
    bioRxiv; 2023 Dec; ():. PubMed ID: 38187573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocytosis of the type III transforming growth factor-beta (TGF-beta) receptor through the clathrin-independent/lipid raft pathway regulates TGF-beta signaling and receptor down-regulation.
    Finger EC; Lee NY; You HJ; Blobe GC
    J Biol Chem; 2008 Dec; 283(50):34808-18. PubMed ID: 18845534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional insights into endoglin ligand recognition and binding.
    Alt A; Miguel-Romero L; Donderis J; Aristorena M; Blanco FJ; Round A; Rubio V; Bernabeu C; Marina A
    PLoS One; 2012; 7(2):e29948. PubMed ID: 22347366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting transforming growth factor beta signaling in metastatic osteosarcoma.
    Ge R; Huang GM
    J Bone Oncol; 2023 Dec; 43():100513. PubMed ID: 38021074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β receptor I/II trafficking and signaling at primary cilia are inhibited by ceramide to attenuate cell migration and tumor metastasis.
    Gencer S; Oleinik N; Kim J; Panneer Selvam S; De Palma R; Dany M; Nganga R; Thomas RJ; Senkal CE; Howe PH; Ogretmen B
    Sci Signal; 2017 Oct; 10(502):. PubMed ID: 29066540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.